Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Takashi, Furuno"'
Autor:
Takehiro Sugiyama, Takashi Furuno, Yuichi Ichinose, Masao Iwagami, Noriko Ihana‐Sugiyama, Kenjiro Imai, Tamaki Kakuwa, Ryoko Rikitake, Mitsuru Ohsugi, Takahiro Higashi, Hiroyasu Iso, Kohjiro Ueki
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 11, Pp 1556-1565 (2024)
ABSTRACT Aims/Introduction A recent US Food and Drug Administration report highlighted concerns over nitrosamine (7‐nitroso‐3‐(trifluoromethyl)‐5,6,7,8‐tetrahydro[1,2,4] triazolo‐[4,3‐a]pyrazine [NTTP]) impurities in sitagliptin, prompt
Externí odkaz:
https://doaj.org/article/071d71aefea945d19368c58cdfbf79ed
Autor:
Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, Kochi YOSACOI study
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2076-2085 (2024)
Abstract Aims This study aimed to evaluate the impact of frailty and living function domains based on the Kihon Checklist (KCL), a questionnaire for a comprehensive frailty assessment, on prognosis in patients with acute heart failure (AHF). Methods
Externí odkaz:
https://doaj.org/article/4c193c889b2640d8879ab4b0a0722a9e
Autor:
Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, Kochi YOSACOI study
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 223-233 (2023)
Abstract Aims Guideline‐directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) is recommended in clinical guidelines, but elderly patients have not fully received GDMT in the clinical situation. The ai
Externí odkaz:
https://doaj.org/article/133733bf5af747f481016cb2f0ebcebf
Autor:
Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, Kochi YOSACOI study
Publikováno v:
ESC Heart Failure, Vol 9, Iss 3, Pp 1853-1863 (2022)
Abstract Aims The aim of this study was to elucidate the clinical characteristics, including frailty status, of patients with heart failure with preserved ejection fraction (HFpEF) in comparison with those in patients with heart failure with reduced
Externí odkaz:
https://doaj.org/article/cd30c1e3b4ec42b3b40a0dd3c1facb7a
Autor:
Toru Kubo, Yuichi Baba, Yuri Ochi, Takayoshi Hirota, Naohito Yamasaki, Kazuya Kawai, Katsuhito Yamamoto, Fumiaki Kondo, Kanji Bando, Eisuke Yamada, Takashi Furuno, Toshikazu Yabe, Yoshinori L. Doi, Hiroaki Kitaoka
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 5022-5030 (2021)
Abstract Aims There is limited information about the clinical significance of atrial fibrillation (AF), particularly new‐onset AF, in patients with hypertrophic cardiomyopathy (HCM) in a community‐based patient cohort. This study was carried out
Externí odkaz:
https://doaj.org/article/1c4b510648f84e658f0bdb2278c7577d
Autor:
Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, the Kochi YOSACOI study
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2876-2888 (2021)
Abstract Aims The aim of this study was to investigate clinical characteristics of frail patients based on a comprehensive frailty assessment in patients hospitalized for acute decompensated heart failure (HF) (ADHF) in super‐aged regional Japanese
Externí odkaz:
https://doaj.org/article/5fd9a69afc644b118bd293b203d6260e
Autor:
Kei Kawada, Toru Kubo, Tomoaki Ishida, Kohei Jobu, Shumpei Morisawa, Tomoyuki Hamada, Yuiti Baba, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hitoshi Fukuda, Tsuyoshi Ohta, Toshinobu Hayashi, Hiroaki Kitaoka, Mitsuhiko Miyamura
Publikováno v:
Journal of Cardiovascular Pharmacology. 79:467-471
Poor adherence to medication in patients with heart failure (HF) is associated with poor clinical outcomes. Although social support has been reported to improve medication adherence in patients with HF, the detailed underlying mechanism of this assoc
Autor:
Hiroaki Kitaoka, Kazuya Kawai, Eisuke Yamada, Toshikazu Yabe, Takashi Furuno, Yuichi Baba, Naohito Yamasaki, Toru Kubo, Yuri Ochi, Fumiaki Kondo, Takayoshi Hirota, Kanji Bando, Yoshinori Doi, Katsuhito Yamamoto
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 5022-5030 (2021)
ESC Heart Failure
ESC Heart Failure
Aims There is limited information about the clinical significance of atrial fibrillation (AF), particularly new‐onset AF, in patients with hypertrophic cardiomyopathy (HCM) in a community‐based patient cohort. This study was carried out to clarif
Autor:
Toru Kubo, Tomoyuki Hamada, Kochi Yosacoi study, Takashi Furuno, Kazuya Kawai, Yoko Nakaoka, Eisuke Yamada, Toshikazu Yabe, Hiroaki Kitaoka
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2876-2888 (2021)
ESC Heart Failure
ESC Heart Failure
Aims The aim of this study was to investigate clinical characteristics of frail patients based on a comprehensive frailty assessment in patients hospitalized for acute decompensated heart failure (HF) (ADHF) in super‐aged regional Japanese cohort.
Autor:
Tomoyuki, Hamada, Toru, Kubo, Kazuya, Kawai, Yoko, Nakaoka, Toshikazu, Yabe, Takashi, Furuno, Eisuke, Yamada, Hiroaki, Kitaoka
Publikováno v:
ESC heart failureReferences.
Guideline-directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) is recommended in clinical guidelines, but elderly patients have not fully received GDMT in the clinical situation. The aim of this study